MRC Laboratory of Molecular Biology Alumni Awarded Nobel Prize for Chemistry|
Monday, October 14, 2013
Professor Michael Levitt, Professor Arieh Warshel and Professor Martin Karplus awarded the 2013 Nobel Prize in Chemistry.
Selcia Appoints New Director of Discovery
Wednesday, October 09, 2013
Appointment of John Davis to the role of Director of Discovery.
Malaria Vaccine Could be Available from 2015
Tuesday, October 08, 2013
GSK candidate reduces disease over 18 Months of follow-up in late-stage study of more than 15,000 infants and young children.
Merck Announces Further Management Changes
Wednesday, October 02, 2013
Stefan Oschmann to focus on role as Head of Pharmaceuticals in charge of Merck Serono, Consumer Health, Allergopharma and Biosimilars.
Chemical Synthesis: A Simple Technique for Highly Functionalized Compounds
Monday, September 30, 2013
Researchers at Kanazawa University have demonstrated a technique that allows direct functionalization of alkenes without the need for metallic reagents, photolysis or extreme reaction conditions.
New Approach to Global Health Challenges
Friday, September 27, 2013
MIT’s Institute for Medical Engineering and Science brings many tools to the quest for new disease treatments and diagnostic devices.
Labcyte Announces Collaboration with AstraZeneca
Wednesday, September 25, 2013
Companies collaborate to use acoustic dispensing combined with mass spectrometry to greatly advance drug discovery applications.
Athera Elects New Chairman of the Board
Monday, September 23, 2013
Company moves to new premises in Stockholm.
Locating and Explaining ‘Activity Cliffs’ in SAR Datasets
Monday, September 16, 2013
Activity Miner from Cresset is an intuitive SAR interpretation tool, identifying key 3D structural and electrostatic changes that impact molecular activity.